The development of the metanephric kidney proceeds through reciprocal interactions between the metanephric mesenchyme and the ureteric bud. One important molecule mediating this interaction is the glial cell line-derived neurotrophic factor Gdnf, which is secreted by the mesenchymal cells. Regulation of Gdnf expression is largely unknown. We show here that a member of the Six family of homeobox containing transcription factors, namely Six2 activates Gdnf expression. We have identified two Six2 binding sites in the Gdnf promoter that show similarity to the consensus DNA binding sequences of other homeobox proteins and harbor short palindromic sequences. Furthermore, we have characterized the Six2 protein and show that Six2 possesses a transcriptional activation domain in the C-terminus and nuclear localization determinants in the Six domain. In order to identify factors which activate expression of Six2, particularly in the metanephric mesenchyme during early kidney development we have cloned and characterized a 930 bp fragment of the murine Six2 promoter. Transgenic mice harboring a construct in which the LacZ gene is driven by the Six2 promoter fragment revealed LacZ expression at multiple sites which overlap with endogenous Six2 expression. Surprisingly, Six2 bound and activated this 930 bp fragment. The architecture of the binding sites in the Six2 promoter, but not the binding sequence itself, is very similar to the one in the Gdnf promoter. The identification of two target genes and our biochemical characterization suggest a critical role for Six2 in kidney development. q
Introduction
In mammals, kidney development proceeds in three successive steps from the initial pronephros via the mesonephros to the adult metanephros. All three stages are characterized by mesenchymal-to-epithelial transformations of cells that are derived from the intermediate mesoderm. It has recently been shown that the competence of the intermediate mesoderm to form kidneys depends on the presence of the Pax2 and Pax8 transcription factors. Without these two proteins, the presumptive intermediate mesoderm undergoes apoptosis (Bouchard et al., 2002) .
One of the two major components of the metanephros is the nephric or Wolffian duct that arises initially as the pronephric duct in the intermediate mesoderm early in development (day 8 in mice). This duct serves as the central component of the excretory system. The second component is the metanephrogenic mesenchyme that induces the formation of an epithelial branch from each of the paired nephric ducts, the so-called ureteric buds. These in turn enter the metanephrogenic mesenchyme. Subsequently, the ureteric bud induces the mesenchyme to condense and differentiate into the nephrons of the mammalian kidney. It is this initial and reciprocal interaction between the two intermediate mesodermal tissues that forms the basis for development of the adult kidney (Vainio and Lin, 2002) .
Because of the fundamental nature of these early interactions, the identification and regulation of factors that mediate them has received a lot of attention. The first signal seems to emanate from the metanephrogenic mesenchyme in the form of diffusible signaling molecules that cause the initial budding of the nephric ducts and elongation of the buds towards the mesenchyme. One critical component of this first signaling is the Gdnf (glial-cell-line-derived neurotrophic factor) molecule, a member of the transforming growth factor b (TGF-b) family. The Gdnf gene is expressed in the metanephrogenic mesenchyme before ureteric bud induction and mice with inactivated Gdnf alleles die soon after birth due to renal agenesis (Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996) . Gdnf acts as a ligand for the c-Ret receptor tyrosine kinase, which is located at the tip of the ureteric bud (Durbec et al., 1996; Trupp et al., 1996) . It has recently been shown that in cells lacking c-Ret the neural cell adhesion molecule NCAM can also function as a signaling receptor for Gdnf (Paratcha et al., 2003) . Local application of Gdnf promotes the formation of primary ureteric buds from various segments of the Wollfian duct and attracts ureteric branches towards the source of Gdnf (Sainio et al., 1997) . Thus, the Gdnf molecule is a key regulator of ureteric bud formation and early kidney development.
Genetic and biochemical data suggest that activation of the Gdnf gene results from the interaction of gene products that seem to be organized in a complex network (Brodbeck and Englert, 2004) . Obviously most of these regulators are transcription factors although the deletion of a signaling molecule encoding gene like Gdf11 (growth/differentiation factor 11) can also result in the loss of Gdnf expression (Esquela and Lee, 2003) . The Pax2 protein has recently been reported to be a direct activator of Gdnf (Brophy et al., 2001 ). Gdnf expression is missing in Pax2 knockout animals and Pax2 can bind to regulatory elements in the 5 0 untranslated region of exon 1 of Gdnf. However, Pax2 does not seem to be the only activator of Gdnf, since in the metanephric mesenchyme of Six1 (an ortholog of the Drosophila sine oculis gene) mutant embryos, Gdnf expression levels are normal whereas Pax2 is markedly reduced (Xu et al., 2003) . Inactivation of the paralogous genes Hoxa-11, Hoxc-11 and Hoxd-11 also leads to loss of Gdnf expression and an arrest of metanephrogenic mesenchyme differentiation (Wellik et al., 2002) . However, expression of Pax2 is normal in these animals.
Another factor that is involved in the regulation of Gdnf expression is the Eya1 gene product, encoded by an ortholog of the Drosophila gene eyes absent. Mutations in Eya1 in humans result in branchio-oto-renal (BOR) syndrome characterized by craniofacial abnormalities, hearing loss and kidney defects (Buller et al., 2001; Rodriguez-Soriano et al., 2001) . Eya1 knockout mice show loss of Gdnf expression (Xu et al., 1999) but since Eya1 cannot stimulate transcription by its own and needs a member of the Six protein family for nuclear translocation (Ohto et al., 1999) it is unlikely that the effect of Eya1 on Gdnf is direct. Eya1 mutant animals also show a loss of Six2 expression and based on this observation one can postulate an Eya1-Six2-Gdnf cascade in early kidney development. Also, in Hoxa/b/ c-11 mutant animals Six2 expression is missing (Wellik et al., 2002) again suggesting that Six2 might be involved in Gdnf regulation.
In mammals 6 Six proteins have been identified that are characterized by an N-terminal Six domain and a central homeodomain (HD) . Both the Six domain and the HD are required for specific DNA binding and the interaction with Eya proteins (Kawakami et al., 1996a; Ohto et al., 1999) . The region C-terminal to the homeodomain is not conserved and varies considerably among Six proteins. Based on amino acid sequence similarities the Six family members can be subdivided into three groups, namely Six1/2, Six3/6 and Six4/5 (Kawakami et al., 2000) . Only the Six4/5 subfamily possesses an extended C-terminal sequence downstream of the homeodomain and it has been shown that the C-terminal 150 amino acids function as an activation domain (Kawakami et al., 1996a) . For the other members no activation domain has been identified so far. In terms of DNA binding specificity Six4 has been shown to bind to the ARE sequence, a transcription regulatory element of the Na, K-ATPase a1 subunit gene (Kawakami et al., 1996a) . Subsequent experiments revealed a similar binding specificity for Six1, Six2, Six4 and Six5 in binding to the ARE/MEF3 site TCAGGTTC (Ohto et al., 1999; Spitz et al., 1998) . With the exception of myogenin and particularly with respect to kidney development no physiologically relevant Six2 target genes have yet been characterized. Interestingly, Six3 and Six6 have recently been shown to functionally interact with members of the groucho family of corepressor proteins suggesting that Six family members might not only activate but also repress downstream genes (Lopez-Rios et al., 2003) .
Among the Six genes only Six1 and Six2 are expressed in the developing kidney. Six1 is expressed in the metanephric mesenchyme and later becomes restricted to a subset of collecting tubule epithelial cells (Xu et al., 2003) . A detailed analysis of Six2 activity revealed expression at E10.5 in the mesenchyme of the nephrogenic cord. At E11.5 the mesonephric tubules express Six2 and at E12.5 expression is restricted to the metanephric mesenchyme surrounding the ureteric buds (Oliver et al., 1995b) . It is not clear which factors activate Six1 and/or Six2 expression in the kidney. An important role for Six1 in kidney development has recently been demonstrated by the generation of the respective knockout mouse, which shows kidney agenesis Li et al., 2003; Xu et al., 2003) . A Six2 knockout mouse has not been reported yet.
We report here a biochemical characterization of the Six2 protein and the identification of physiological Six2 target genes. Cellular localization studies and further biochemical experiments indicate that the Six domain of Six2 is responsible for targeting the protein to the nucleus and demonstrate that the C-terminus of Six2, in particular the last 60 amino acids can act as a transcriptional activation domain. In a search for Six2 targets we have identified Gdnf and, surprisingly, Six2 itself as downstream genes that are activated by the Six2 transcription factor. Our data thus show that Six2 is a bona fide transcription factor and suggest that it fulfils a critical role in early kidney development by activating the Gdnf gene. In addition, our data point to the existence of a positive regulatory loop in kidney organogenesis.
Results

Six2 is a bona fide transcription factor
With the exception of Six4 and Six5, which possess an extended C-terminal domain (Kawakami et al., 2000) , an activation function has not yet been identified for Six family members. Also, the subcellular localization of the Six proteins has not been studied in detail. We have therefore fused the individual domains of Six2 (Fig. 1A ) with a FLAG epitope tag and used immunofluorescence in Cos cells to analyze the subcellular distribution of the proteins. Full-length Six2 could only be detected in the nucleus whereas all the three individual domains (the Six-, homeo-and C-terminal domain) were localized in both the nucleus and the cytoplasm (Fig. 1B) . Of those, however, the Six domain showed a much stronger tendency to accumulate in the nucleus and a protein consisting of the Six domain and the homeodomain was found to be localized exclusively in the nucleus. Conversely, a fusion of the homeodomain and the C-terminus was primarily localized in the cytoplasm. Finally, a fusion of the Six domain to the C-terminus, i.e. the deletion of the homeodomain also led to an almost exclusive localization in the nucleus. Together these data demonstrate that one of the functions of the Six domain is to serve as a nuclear localization signal.
We next wanted to assess whether the Six2 protein possesses a transcriptional activation potential. For this we fused the different domains of Six2 to the DNA binding domain of Gal4 and tested the activation of a Gal4-responsive reporter in transient transfection assays. All Gal4 fusion constructs were expressed at comparable levels (data not shown). In this experimental context the full-length construct as well as those constructs encoding the Six Q domain showed two-to three-fold repression compared to the empty vector. In contrast, the C-terminus showed a small but significant activation of the reporter gene (Fig. 1C , top). When fused to the homeodomain, however, activation increased to more than tenfold. Since the homeodomain itself did not activate the reporter plasmid, these data suggest that the C-terminal domain of the Six2 protein can act as a potent transcriptional activator. Deletion of the C-terminal 17 amino acids reduced the activation potential of the homeodomain/C-terminal fusion protein to about 50% and successive shortening by additional 34 amino acids to 20% of its initial activity (Fig. 1C, bottom) . Thus, the activation domain of the Six2 protein resides in the C-terminal portion of the molecule, more specifically in the last 60 amino acids.
Six2 activates the Gdnf gene
There are primarily genetic studies that point to a possible activation of the Gdnf gene by the Six2 (and Six1) transcription factor (Wellik et al., 2002; Xu et al., 1999) . We therefore wanted to test whether the Gdnf promoter can be activated by Six2. For these experiments we used a 3.6 kbp Gdnf promoter fragment that encompasses promoter 1, TATA-box, the main transcriptional start site and exon 1 of the murine Gdnf gene (Tanaka et al., 2000) as well as additional 5 0 sequences ( Fig. 2A ). In transient transfection (Tanaka et al., 2000) . Labeled fragments were incubated without or with recombinant GST-Six2 protein and subjected to EMSA (bottom). (D) DNase I footprinting analysis of the F5 Gdnf promoter fragment (nucleotides 2 437 to þ 7). The fragment was 5 0 -labeled, incubated with recombinant GST (control) or GST-Six2 protein and subjected to partial DNase I digestion. Sequencing was performed using the same primer as for the footprinting experiment. The two regions protected by GST-Six2 are indicated by boxes. The sequences of the two binding sites reveal a common 9 bp motif encompassing an ATTA sequence (bold). Binding site II harbors the motif in the reverse complementary orientation compared to binding site I. (E, F) EMSA analysis of two 120 bp Gdnf promoter fragments (E) and wildtype and mutated BSI containing oligonucleotide duplexes (F). Labeled probes were incubated without protein, with recombinant GST or GST-Six2 protein. The oligonucleotide sequence is indicated below. In the mutant sequence the underlined T residues were changed to G.
Q experiments Six2 significantly stimulated reporter gene activity whereas the transcription factors Pax2, Eya1 and Wt1 did not show any effect (Fig. 2B ). This is somewhat surprising since it has been shown recently that Pax2 can activate Gdnf expression (Brophy et al., 2001 ) but might be explained by the fact that the Pax2 binding site in the Gdnf gene lies at the extreme 3 0 -end of our promoter construct. In order to map the Six2 binding site in the Gdnf promoter we used a combination of electrophoretic mobility shift assays (EMSA) and DNase I footprinting experiments. We used PCR to generate seven overlapping fragments (F1 -F7) that encompass the complete 3.6 kbp promoter construct. EMSA analysis with recombinant GST-Six2 protein revealed a weak retardation of fragments F3 and F4 and a strong gel shift of fragment F5 (Fig. 2C) . The latter harbors the TATA-box and the main transcriptional start site of Gdnf. In subsequent footprinting analysis only fragment F5 gave two recognizable DNase I footprints (Fig. 2D) . The regions that were protected by GST-Six2 extend from nucleotides 2 279 to 2 253 (binding site I, BSI) and from 2 188 to 2 167 (binding site II, BSII), relative to the transcriptional start site. To verify these results we generated four overlapping 120 bp fragments that encompass the 410 bp F5 fragment and performed EMSA analysis. Of those fragments, F5/2 (nucleotides 2 333 to 2 221) and F5/3 (nucleotides 2 242 to 2 121) were bound by the Six2 protein (Fig. 2E ) whereby the upstream sequence was bound more strongly. The EMSA analysis thus supported the results obtained by the DNase I footprinting experiments in that fragment F5 of the Gdnf promoter contains two Six2 binding sites. Both sites harbor an identical 9-mer motif TGTATTACA containing an ATTA core sequence that is a typical binding site for homeodomain proteins. The orientation of the 9-mer sequence in BSII is the reverse complement to the one in BSI.
To characterize the molecular interactions between the Six2 protein and the Gdnf promoter sequences we introduced different mutations into the sequences BSI and BSII. Initially we exchanged individual nucleotides within the two binding sequences and obtained similar results for BSI and BSII. The introduction of point mutations led to a decrease in Six2 binding that was drastic in the case of the ATTA box (Fig. 2F ) and still significant when base pairs outside this element were affected. Mutation of nucleotides outside BSI and BSII did not affect Six2 binding (data not shown).
The deletion of one of the binding sites in the context of fragment F5 yielded the same results as the simultaneous introduction of two or three point mutations into the respective site. The results obtained with the point mutations are shown here (Fig. 3A) . Mutation of BSI led to a strong reduction in Six2 binding as revealed by EMSA whereas mutation of BSII only had a very minor effect (Fig. 3B) . Simultaneous mutation of both sites abolished binding of Six2 to the F5 fragment.
We next carried out transactivation studies using Cos7 cells as well as the murine mesonephric cell line M15.
In both cases identical results were obtained. When using the F5 fragment for transactivation experiments we noted a significant drop in activity when compared to the 3.6 kbp fragment that we had used for our initial characterization. With F5 only a threefold Six2-mediated activation could be observed (Fig. 3C ). This might be due to the presence of additional Six2 binding sites in fragments F3 and F4 that we had detected by EMSA but not by footprinting analysis (see Fig. 2C ). Indeed, when we used a construct harboring fragments F4 and F5 in front of the reporter gene we observed an increase in transactivation level. Mutation of either BSI or BSII alone in the context of the F5 fragment as well as simultaneous mutation of both sites led to a reduction of F5 activation to background levels. This suggests that although there seem to be significant differences in binding affinity between BSI and BSII both sites are required for full Six2 activity. 
A 930 bp fragment of the Six2 promoter contains important regulatory elements
After having characterized Gdnf as a Six2 target we next wanted to gain insights into cis-regulatory elements of the Six2 gene. The murine Six2 regulatory region has not yet been characterized and we used the N-terminal Six domain of Six2 as a probe in order to clone a 930 bp fragment that is located upstream of the Six2 coding region (Fig. 4A) . Sequencing of the fragment revealed significant homology to the human SIX2 upstream region encompassing two predicted transcriptional start sites (Boucher et al., 2000) . (Boucher et al., 2000) . S1-S3 indicate the position of the probes used for EMSA. SD Six domain, HD homeodomain; (B) Alignment between human and mouse Six2 promoter sequences. The overall homology is 80%. Putative transcriptional start sites are bold. The alignment was done using the Bestfit programme of the UWGCG package. The sequence data have been submitted to the EMBL database under accession number AJ586912. (C) Analysis of an 11.5-day-old embryo transgenic for the murine Six2 promoter fragment. The construct used harbors a 930 bp fragment of the murine Six2 promoter region followed by the LacZ gene carrying an NLS at its 5 0 terminus. (D)
Transverse section through the region of the metanephros of a transgenic E11.5 embryo. b, branchial arches; n, neural tube; oe, oesophageal region; s, somites; u, urogenital ridge; mm, metanephric mesenchyme; ub, ureteric bud.
Particularly in their 3 0 regions the 930 bp murine fragment and the human sequence show long stretches of identity (Fig. 4B) indicating that these sequences might be functionally important.
To examine the functionality of the 930 bp Six2 promoter fragment we cloned it in front of the LacZ gene and generated transgenic mouse lines. Three independent transgenic lines were obtained of which two passed on the transgene. Both lines displayed an almost identical pattern of LacZ expression. At day 11.5 of embryonic development the latter could be observed in the urogenital ridge, the somites, the oesophageal region and the branchial arches (Fig. 4C) . A more detailed analysis of LacZ expression in the developing kidney revealed staining of the mesenchyme surrounding the ureteric buds of the metanephros (Fig. 4D ). This pattern of LacZ activity is in very good agreement with endogenous Six2 expression (Oliver et al., 1995b) and indicates that the 930 bp Six2 promoter fragment harbors sequences that are responsible for the tissue-specific expression of Six2 for example in the kidney.
Six2 activates its own promoter
After having established that the 930 bp fragment of the Six2 promoter contains sequences that direct expression in the physiologically relevant tissues we tested some candidate transcription factors for their ability to activate the respective promoter fragment. In transient transfection experiments the proteins Eya1, Pax2 and Wt1 all of which are present in the metanephric mesenchyme were not able to stimulate reporter gene activity driven from the 930 bp fragment (Fig. 5A ). To our surprise, however, we observed a very robust activation by the Six2 protein itself. It has been reported that Eya1 itself does not function as a transcription factor per se but needs an additional factor, e.g. a member of the Six proteins to exert its transcriptional activity (Ohto et al., 1999) . We therefore tested a possible cooperative effect of Eya1 and Six2 on the Six2 promoter activation. To do this we reduced the amount of Six2 plasmid to a level which itself is not able to activate the reporter gene. Cotransfection with an Eya1 encoding plasmid resulted in a dose-dependent increase in reporter gene activity (Fig. 5A , inset) demonstrating cooperation of Eya1 and Six2 on the Six2 promoter fragment.
To characterize the Six2 binding sites in the Six2 promoter we used three overlapping 320 bp fragments (S1 -S3) and performed an EMSA experiment. Only in the case of S3 a significant gel shift could be observed with recombinant GST-Six2 protein (Fig. 5B, top) . To define the binding sites more precisely we generated three overlapping 130 bp fragments that encompass the S3 sequence and again performed EMSA analysis. Fragments S3/1 (nucleotides 604 -739) and S3/2 (nucleotides 724 -839) were bound by the Six2 protein (Fig. 5B,  bottom) . DNase I footprintig analysis confirmed the presence of two regions that were protected by Six2 (Fig. 5C ) and extended from positions 701 to 717 (Six2BSI) and 777 to 799 (Six2BSII). The first binding site, Six2BSI harbors a motif TCGGGTTA that is identical to the reverse complementary sequence of TAACCCGA, which is contained in the second binding site Six2BSII. This is very reminiscent of the Six2 binding sites in the Gdnf promoter. In contrast to the Gdnf promoter neither binding site in the Six2 promoter, contains an ATTA sequence but either a TTA or a TAA motif, respectively. To characterize the contribution of these motifs to Six2 binding we carried out gel shift analyses using 25 bp oligonucleotide duplexes encompassing the binding sites Six2BSI or Six2BSII. Interestingly, point mutations of the TTA and TAA motif but not other neighboring nucleotides abolished Six2 binding (Fig. 5D top) . The contribution of the TTA motif to Six2 binding was also underscored by a competition experiment. In the case of Six2BSI an excess of a wildtype oligonucleotide but not a mutant oligonucleotide carrying a TGC instead of a TTA motif could compete with the labeled probe for Six2 binding (Fig. 5D, bottom) . Identical results were obtained for Six2BSII (data not shown).
To study the relation between Six2 binding and activation of the Six2 promoter we deleted both Six2 binding sites either separately or in combination. Deletion of Six2BSI led to a strong reduction of Six2 binding. This residual binding was completely abrogated by the additional deletion of the second binding site Six2BSII (Fig. 5E) . Deletion of the latter alone, however, only had a very small effect on Six2 binding. Different effects were observed when the deletion constructs were characterized in transactivation assays. As in the case of the Gdnf promoter fragment, Cos7 and M15 cells were used yielding identical results. Here the deletion of the second binding site led to a more prominent reduction in Six2-mediated activation than deletion of the first one (Fig. 5F ). This indicates a discrepancy between the requirements for binding of the Six2 protein and those for activation of the Six2 promoter fragment. Even when both sites were deleted an approximately fivefold activation could still be observed which might be explained by the existence of additional Six2-responsive sites in the S3 fragment that were not detected by our initial EMSA analysis.
Discussion
The development of the mammalian metanephric kidney is controlled by a number of genes that interact in a biochemical and genetic network (Vainio and Lin, 2002) . There are mainly genetic data that suggest that members of the Six gene family, in particular Six1 and Six2 are part of this network. We have focused on one of the genes, Six2 and provide strong evidence that the Six2 protein acts as a transcription factor and activates the Gdnf gene, which itself is a key mediator of early kidney development. In addition, our data suggest that Six2 can activate its own promoter. It has been shown that the N-terminal Six domain of most Six family members has two functions. Together with the homeodomain it mediates specific DNA binding (Kawakami et al., 1996a) and, again together with the homeodomain, it serves as a platform for the interaction with Eya family members in order for the latter to be translocated into the nucleus (Ohto et al., 1999) . Our data suggest that the Six domain fulfils an additional function in that it is responsible for the nuclear localization of Six2. Whereas the Six domain alone could be found in the cytoplasm as well as in the nucleus (probably because of the small size), any fusion protein that contained the Six2 domain was exclusively localized in the nucleus. However, we could not detect an obvious NLS in the Six2 protein sequence.
Regarding the transactivation properties of Six2 our experiments using a heterologous promoter define the Cterminal portion of the protein as an activation domain. This activity was pronounced when we used a fusion of the homeodomain and the C-terminus and could be attributed to the last 60 amino acids. The corresponding sequence displays a high content of serine (24 of the last 113 aa) and proline (17 of the last 75 aa) residues, which is typical for transactivation domains. Whereas the C-terminus activated transcription of the reporter gene, the full-length protein as well as all the fusions that harbored the Six domain showed significant repression. This might be explained by a possible interaction with transcriptional corepressors. The recent observation that the Six domain of Six3 and Six6 (but not Six2) is able to mediate an interaction with members of the groucho family of corepressors (Lopez-Rios et al., 2003) is one example. As with a number of transcription factors including for example the Pax5 protein (Eberhard et al., 2000) this opens up the possibility that depending on the presence of cofactors and on the respective promoter context the Six proteins including Six2 might function as activators as well as repressors of transcription.
Most importantly, our data provide evidence that Six2 fulfils a critical function in early kidney development by activating the Gdnf gene. The observation that in Eya1 and Hoxa/b/c-11 knockout mice displaying renal agenesis Six2 and Gdnf expression are missing (Wellik et al., 2002; Xu et al., 1999) , had already pointed to the possibility that the latter act in the same pathway. Our biochemical experiments support this hypothesis and with Gdnf we have identified the first physiologically relevant target of Six2. Gdnf expression is missing in Pax2 knockout animals and Pax2 has been shown to activate the Gdnf promoter directly (Brophy et al., 2001) . In a very recent report, chromatin immunoprecipitation and microinjection assays revealed binding and activation of Gdnf intron 1 by the Six1 protein (Li et al., 2003) . Thus, a combination of Pax2, Eya1, Six2, Six1 and the Hox11 proteins regulate the expression of Gdnf in the metanephrogenic mesenchyme according to our current knowledge. Remarkably, many of the components regulating early kidney development are conserved throughout evolution and are also involved in eye (Eya1, Six3, Pax6) and muscle formation (Six1, Six4, Pax3) in mammals as well as in eye development in Drosophila (Spitz et al., 1998; Treisman, 1999) . In the latter case the eyeless and twin of eyeless genes encode Pax-6 proteins and together with eye gone, sine oculis (the ortholog of the Six genes), eyes absent (the ortholog of the Eya genes) and dachshund drive Drosophila eye morphogenesis.
The two Six2 binding sites that we have identified in the Gdnf promoter are separated by 64 base pairs and encompass an ATTA box, a typical binding sequence for homeodomain proteins. Another remarkable feature is the presence of a 9 bp sequence that is present in one binding site and in its reverse complementary orientation in the second site. Moreover, a very similar architecture regarding the Six2 binding sites can also be found in the Six2 promoter that is also activated by the Six2 protein. In this case the two binding sites are separated by 59 base pairs and harbor an 8 bp palindromic sequence. In the case of the Six2 promoter, however, no full ATTA sequence but a TTA and a TAA motif is present. As shown by our mutagenesis studies and competition experiments these motifs are essential for Six2 binding in that point mutations of these sequences abrogate binding. In fact the DNA sequences that have been shown to interact with Six proteins do usually not contain an ATTA core (Kawakami et al., 1996b) . This is probably due to the fact that the homeodomain of Six family members is unusual in that it lacks two highly conserved amino acids that usually contact the conserved homeobox binding core sequence (Kawakami et al., 2000) . This might expand the repertoire of possible Six2 binding sites and explain why it is not possible to delineate a consensus sequence for Six protein binding sites from the sequences published to date. Even the two pairs of binding sites reported here do not show a significant similarity and it is tempting to speculate that Six2 requires a combination of sequence and structure or spacing in order to bind rather than a strict sequence. On this basis Six2 could be called an architectural rather than a sequence-specific transcription factor, which we would predict to bind to DNA as a dimer.
and three deletion mutants missing the first, second or both Six2 binding sites (indicated by boxes). EMSA analysis (bottom) of wild type and mutated fragments S3, S3D1, S3D2, S3D1 þ 2. Labeled fragments were incubated without or with recombinant GST-Six2 protein and subjected to EMSA. (F) Activation of wild type and mutated S3 fragments by Six2. Cos-7 cells were cotransfected with an expression vector for Six2 and reporter constructs carrying the respective wild type or mutated S3 Six2 promoter fragments. Results are given as relative activation of the reporter by the expression constructs compared to the empty vector. Data represent the mean and standard deviation of three independent experiments.
After having established a link between Six2 and its downstream target Gdnf, we wanted to address the problem which factors would activate the Six2 gene. In order to do this we had to first identify the sequences necessary for the tissue-specific expression pattern of Six2. In our attempts to define cis-regulatory elements in the murine Six2 promoter we have cloned and subsequently used a 930 bp fragment of the Six2 upstream region. Given the size of the fragment it seems unlikely that it is able to mimic full endogenous Six2 expression. Nevertheless this fragment activated LacZ expression in a way that was very similar to the expression pattern of the Six2 gene, most notably in the metanephric mesenchyme at stage E11.5 suggesting that it harbors elements that are sufficient to direct Six2 expression in the kidney in vivo.
While our finding that Six2 activates Gdnf is supported and almost anticipated by genetic experiments, the observation that Six2 activates its own promoter is rather surprising. One possible explanation is the existence of a positive feedback loop whereby Six2 stimulates transcription of its own gene thus helping to increase gene expression in a short window of time. In that case one would look at the maintenance of gene expression rather than its initiation and has to postulate additional factors that initiate Six2 expression. An alternative possibility is that our observation relates to a possible redundancy of Six genes in metanephric development. Both Six1 and Six2 are expressed in the metanephric mesenchyme (Oliver et al., 1995a; Xu et al., 2003) and given the high similarity of the two proteins (Kawakami et al., 2000) it seems plausible that it is actually Six1 that activates Six2 expression. This would be consistent with the lack of Six2 expression in Six1 knockout embryos that has recently been reported (Xu et al., 2003) . The two explanations do not necessarily exclude each other but in order to clarify the role of Six1 and Six2 in kidney development more precisely a more thorough analysis of the time-course of expression as well as the biochemical properties of both proteins is required. In addition, the Six2 knockout mouse might yield addition insights into the dependencies of the different members of the Pax/Eya/Six/ Gdnf network in kidney development.
Methods
Cell culture and immunofluorescence
M15 cells (mouse, mesonephros) and Cos7 cells (monkey, kidney) were obtained from the European Collection of Cell Cultures, ECACC and grown in DMEM supplemented with 10% FCS. For immunofluorescence analysis, cells were grown on coverslips, transfected (using SuperFect, Qiagen) and 48 h later fixed with 4% (w/v) paraformaldehyde. After permeabilization with 1% Nonidet P-40 in 10 mM glycine, cells were preadsorbed with 3% (w/v) bovine serum albumin (BSA) and exposed to the anti-FLAG antibody (rabbit polyclonal, Sigma). Coverslips were then incubated with a rhodamine-conjugated goat anti-rabbit antibody (Jackson ImmunoResearch) and examined by using a Zeiss Axiophot microscope.
Constructs and plasmids
The various Six2 constructs were made by PCR-mediated cloning of the Six domain (aa 1 -123), the homeodomain (aa 124-183) and the C-terminus (aa 184 -497) of Six2 or combinations thereof into different target vectors. Fulllength Six2 (a gift of K. Kawakami) served as a template. For the generation of the Gal4 fusion proteins the amplified products were cloned into the EcoRI and XbaI sites of the pM vector (BD Clontech). For the localization studies amplified fragments were cloned into the KpnI and XhoI sites of the pcDNA3.1 vector (Invitrogen) that had previously been modified to harbor a FLAG epitope encoding sequence between the NheI and KpnI sites. To make recombinant GST-Six2 protein the full-length Six2 cDNA was cloned into the EcoRI and XhoI sites of pGEX-KG (Guan and Dixon, 1991) .
The reporter construct for the Gal4 assays (5xGal4-Tk109luc) harboring five Gal4 binding sites in front of a minimal Tk promoter (pos. 2 109 to þ 52) followed by the luciferase gene and was based on 5xjun2-Tk-luciferase (van Dam et al., 1998) .
Reporter gene assays
Cells were split at 1.2 £ 10 5 cells per well into six-well dishes and transfected 24 h later with 0.6 mg reporter plasmid, 0.7 mg expression plasmid and 0.1 mg internal control plasmid encoding Renilla luciferase (with a total of 2 mg plasmid DNA per well) using SuperFect (Qiagen) as described by the manufactures. Reporter gene activity was determined 48 h after transfection using the Dual-Luciferase system (Promega). Values were normalized for transfection efficiency and with respect to the effects of the expression constructs on the empty pGL3basic reporter plasmid.
As a second reporter gene system, secreted alkaline phosphatase (SEAP) was used. Transfections were carried out as described above with 0.6 mg reporter plasmid, 0.7 mg expression plasmid and 0.1 mg internal control plasmid. SEAP assays were performed according to the recommendations of the manufacturer (BD Clontech).
Electrophoretic mobility shift assays
EMSA analysis was performed using recombinant, bacterially expressed GST fusion protein of full length Six2 (GST-Six2). Gdnf and Six2 promoter fragment probes were obtained through PCR amplification, using the 3.6 kbp Gdnf or the 930 bp Six2 promoter fragment as template, and subsequent gel purification. EMSA experiments were performed as described previously (Wilhelm and Englert, 2002) .
Introduction of point mutations into the Gdnf promoter were made with Quick Changee Site-Directed Mutagenesis Kit (Stratagene) using two primers for each mutation which carried two or three base changes, respectively (F5mutI: BSI/5, CCC ACG TCT GGT ATT GTA GTA AAA CAG CAT GGA AAT GAA GC; BSI/3, GCT TCA TTT CCA TGC TGT TTT ACT ACA ATA CCA GAC GTG GG; F5mutII: BSII/5, CTT CAT TGC CGG CCA TGT CCG ACA TGA TAT GCA AAG CCT CTG; BSII/3, CAG AGG CTT TGC ATA TCA TGT CGG ACA TGG CCG GCA ATG AAG). Deletions of Six2 binding sites of the Six2 promoter were done by ExChangee PCR-Based SiteDirected Mutagenesis Kit (Stratagene) using two deletion sequence flanking primers (S3D1: SixdelI/5, CAG CGT CTC CAT GGC GAA TA; SixdelI/3, GCG GCT CCC ACC CCC G; S3D2: SixdelII/5, CCT CAT GCC CGC TTA GAA T; SixdelII/3, CCA GAC AAT AGT CGA GTC AAA). Primers were phosphorylated at their 5 0 ends.
DNase I footprinting analysis
For footprinting analysis the 413 bp fragment F5 of the Gdnf promoter and the 354 bp fragment S3 of the Six2 promoter fragments were generated by PCR using one 32 P-labeled 5 0 -and one non-labeled 3 0 -primer (Gdnf: Shift5, TTG TTT TCG GGC CTG CCT AGT G; Shift3, TGT GTT CTG GAA GAA GCT GAG AC; Six2: SP5, GCT CCC GTC GTC GCC AAC T; SP3, AGC AGC AGC AGC AGC ATG GT). PCR fragments were gel-purified, and probes were incubated with 50 mg of GST or GST-Six2 protein.
The DNase I footprinting reaction as well as the subsequent analysis of reaction products was performed as described previously (Wilhelm and Englert, 2002 ). All footprinting analyses described in this paper were made from both directions, i.e. in two independent experiments either one of the flanking primers was labeled. Since identical results were obtained with both individual primers only one experiment is shown in each case.
Cloning of a Six2 promoter fragment
A probe covering the Six domain of Six2 (aa 1-115) was used to screen a mouse genomic library (mouse cosmid, number 121) provided by the RZPD (Resource Center/ Primary Database, Heidelberg, Berlin). This library contains inserts of approximately 38 kb derived from genomic DNA from the spleen of male mice (strain: 129/ola) in the vector Lawrist 7. After re-screening three positive clones were obtained and one of these clones was then used to analyze the Six2 locus in more detail. Characterization was done using a combination of restriction enzyme digestion, Southern Blotting, subcloning and sequencing. Finally, a 930 bp BamHI/EcoRI fragment, localized 5 0 of the translational initiation ATG was cloned into the vector pSeap2-Basic (BD Clontech) and named SPB. These sequence data have been submitted to the EMBL database under accession number AJ586912.
Generation and analysis of transgenic mice
Mice carrying the LacZ gene under the control of a fragment of the murine Six2 promoter were generated by standard pronuclear injection into fertilized eggs (Hogan, 1994) and maintained on a C57BL/6J background. The construct SPBLacZ was made by PCR reaction on SPB vector as a template using the primers SPLacZ5 (ACT GAA GCT TTC CGG GAA GTT GAT TCT CAG G) and SPLacZ3 (AGC ATG GCC ATG GTG GCG G). The primers carry an EcoRI and an NcoI site, respectively. The PCR product was ligated into the vector pSKT-NLS-LacZ. This vector provides the LacZ gene carrying a nuclear localization signal at the N-terminus (Bonnerot et al., 1987) . The integrity of the construct was verified by sequencing.
For the SPBLacZ construct three transgenic founder mice were obtained. One founder animal was sterile, the other two were used to establish two independent transgenic lines. For each line lacZ expression was analyzed using at least 15 transgenic embryos.
Mice were genotyped by PCR using primers LacZfor (ATC AGC GAT TTC CAT GTT GCC) and LacZrev (AGA CCA TTT TCA ATC CGC ACC). Transgene expression was assayed by X-gal staining of embryos following standard procedures (Hogan, 1994) . After completion of the colour reaction, the embryos were washed 3 £ in PBS and postfixed in 4% paraformaldehyde for 30 min, washed in PBS and transferred to 40% glycerol/50% formamide/PBS for storage and photography. Alternatively, samples were embedded in 0,44% gelatine/27% albumine/18% saccharose/ 2,6% glutaraldehyde and cut into 20 mm transverse sections.
